Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathogen patterns in viral ARDS on V-V ECMO: a single-center experience.

Infection·2026
Same author

Association of high-sensitivity cardiac troponin T with all-cause and cardiovascular mortality in a mobile cohort of older adults aged 70 to 95 years - Results from the AugUR study.

American journal of preventive cardiology·2026
Same author

Peripartum-Associated Heart Failure Develops Independently of RHOT Proteins.

International journal of molecular sciences·2026
Same author

Differential effects of transcatheter edge-to-edge repair on forward stroke volume in atrial and ventricular secondary mitral regurgitation.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Tubular Biomarkers N-Acetyl-ß-D-Glucosaminidase, Kidney-Injury-Molecule 1 and Neutrophil Gelatinase-Associated Lipocalin: Long-Term Follow-Up in a Chest Pain Cohort.

Cardiorenal medicine·2026
Same author

Dyssynchronous heart failure: mitochondrial distribution and functions mirror regional workload and energy demand in a large-animal model of ventricular desynchronization.

European journal of heart failure·2026

Related Experiment Video

Updated: May 19, 2026

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Proteomic profiling implies mitochondrial dysfunction in tachycardia-induced heart failure.

Christoph Birner1, Alexander Dietl, Rainer Deutzmann

  • 1Department of Internal Medicine II, University Regensburg, Regensburg, Germany. christoph.birner@klinik.uni-regensburg.de

Journal of Cardiac Failure
|August 4, 2012
PubMed
Summary

Congestive heart failure alters protein expression in the ventricles, particularly affecting cellular energy metabolism. These changes differ between the left and right ventricles and between healthy and failing states.

More Related Videos

Robust Mitochondrial Isolation from Rodent Cardiac Tissue
07:03

Robust Mitochondrial Isolation from Rodent Cardiac Tissue

Published on: August 23, 2024

Analyzing Mitochondrial Function in a Drosophila melanogaster PINK1B9-Null Mutant Using High-resolution Respirometry
09:20

Analyzing Mitochondrial Function in a Drosophila melanogaster PINK1B9-Null Mutant Using High-resolution Respirometry

Published on: November 10, 2023

Related Experiment Videos

Last Updated: May 19, 2026

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Robust Mitochondrial Isolation from Rodent Cardiac Tissue
07:03

Robust Mitochondrial Isolation from Rodent Cardiac Tissue

Published on: August 23, 2024

Analyzing Mitochondrial Function in a Drosophila melanogaster PINK1B9-Null Mutant Using High-resolution Respirometry
09:20

Analyzing Mitochondrial Function in a Drosophila melanogaster PINK1B9-Null Mutant Using High-resolution Respirometry

Published on: November 10, 2023

Area of Science:

  • Proteomics
  • Cardiovascular Biology
  • Molecular Mechanisms of Disease

Background:

  • Congestive heart failure (CHF) molecular mechanisms, especially protein expression changes, are not fully understood.
  • Investigating intraventricular and interventricular protein expression differences in heart failure is crucial.

Purpose of the Study:

  • To analyze intraventricular and interventricular protein expression differences in a rabbit model of tachycardia-induced heart failure.
  • To identify key proteins and pathways altered in left ventricular (LV) and right ventricular (RV) heart failure.

Main Methods:

  • Utilized a rapid ventricular pacing rabbit model to induce heart failure.
  • Employed 2D gel electrophoresis and MALDI-MS/MS for proteomic analysis and protein identification.

Main Results:

  • Heart failure induced by pacing showed LV dilatation, dysfunction, and hypotension.
  • LV-CHF revealed underexpression of proteins in cellular energy metabolism compared to LV-CTRL.
  • RV-CHF showed underexpression of respiratory chain proteins and nitric oxide pathway disturbances.
  • Failing LV exhibited stronger energetic pathways but underexpressed contractile/stress proteins compared to failing RV.
  • Differences in contractile, stress, and respiratory proteins were observed between control LV and RV tissues.

Conclusions:

  • Tachycardia-induced heart failure presents significant inter- and intraventricular protein expression alterations.
  • Protein expression changes predominantly involve pathways related to cellular energy metabolism.